nivolumab
bms
['melanoma', 'nivo']
another great talk by at #smr2022 . adjuvant nivo for stage iib/c #melanoma reduces recurrences even after a 1 year follow up. #immunotherapy keeps marching on 
Medical oncologist, @lemelbaum institute for immuno-oncology. Treating patients with #Melanoma, interested in #Immunotherapy and clinical trials